abrdn plc Invests $1.72 Million in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
abrdn plc purchased a new stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 230,745 shares of the company’s stock, valued at approximately $1,719,000. A number of other hedge funds have also bought and […]
![abrdn plc Invests $1.72 Million in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/eyepoint-pharmaceuticals-inc-logo-1200x675.png?v=20221222155024&w=240&h=240&zc=2)